Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
algorithm
Alzheimer's disease
Alzheimer's disease, diagnosis of
Alzheimer's disease, incidence
Alzheimer's disease, prognosis of
Alzheimer's disease, risk factors in
Alzheimer's disease, treatment of
amyloid beta protein
anticoagulant, treatment
antiphospholipid antibodies
apolipoprotein E
biologic markers
carcinoma
CAT scan
CAT scan, abnormal
CAT scan, emission, abnormal
CAT scan, venography
cerebral edema, vasogenic
cerebral infarction
cerebral venous infarction
cerebral venous thrombosis
cerebral venous thrombosis, deep
cerebral venous thrombosis, etiology
cerebral venous thrombosis, recurrent
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, prevention of
cerebrovascular accident, thrombolytic agents in treatment
children
complications
craniectomy, decompressive
D-dimer
degenerative diseases of CNS
dementia
dementia, cerebrovascular disease causing
dementia, clinical diagnosis
dementia, diagnostic classification
dementia, differential diagnosis of
dementia, incidence
dementia, prevalence of
dementia, prevention of
dementia, treatment of
diabetes mellitus
dural sinus thrombosis
educational status
endovascular therapy
epidemiology of neurology
evidence-based research
Factor V Leiden
fibrinolytic agents
fibrinolytic agents, intra-venous local infusion
gadolinium
gene
genetic neurologic disorders
headache
hydrocephalus
incidence
interobserver agreement
intracranial pressure, increased
inverse association
leisure activity
level of consciousness, decreased
lifestyle
Mini Mental Status Examination
misdiagnosis
mortality
MRI
MRI, abnormal
MRI, CAT scan compared to
MRI, contrast enhanced
MRI, venography
neurologic complications of, systemic disease
neurologic disease, diagnoses of
neurologic examination, focal
neuroprotective agents
old age, neurology of
oral contraceptives
pitfalls
practice guidelines
pregnancy, neurologic complications in
prethrombotic state
prevention of neurologic disorders
prognosis
protein C deficiency
protein S deficiency
psychological testing
review article
rhinorrhea, CSF
risk factors
seizure
sodium-glucoe cotransporter-2 inhibitors
tau protein
tissue plasminogen activator, intravenous
treatment of neurologic disorder
workup
Showing articles 850 to 900 of 910 << Previous Next >>

Biologic Distinction Between Sporadic & Familial Alzheimer Disease by an in vitro Cell Fusion Test
Neurol 31:323-325, Dubois-Moreau,M.C.,et al, 1981

Myoclonus in Down's Syndrome
Arch Neurol 38:453-454, Blumbergs,P.,et al, 1981

Cerebral Vasodilators (Second of Two Parts)
NEJM 305:1560-1564, Cook,P.,et al, 1981

Alzheimer Disease:Lack of Effect of Lecithin Treatment for 3 Months
Neurol 31:1552-1554, Etienne,P.,et al, 1981

Parkinson Disease, Dementia, & Alzheimer Disease:Clinicopathological Correlations
Ann Neurol 7:329-335, Boller,F.,et al, 1980

Evidence For & Against the Transmissibility of Alzheimer Disease
Neurol 30:945-950, Goudsmit,J.,et al, 1980

Amygdaloid Changes in Aging & Dementia
Arch Neurol 37:625-629, Herzog,A.G.,et al, 1980

Demonstration of CSF Gamma-globulin Banding in Presenile Dementia
Neurol 30:882-884, Williams,A.,et al, 1980

Decreased Computerized Tomography Numbers in Patients With Presenile Dementia
Arch Neurol 37:401-409, Naeser,M.A.,et al, 1980

Presenile Alzheimer Disease:Amyloid Plaques in the Cerebellum
Neurol 30:820-825, Pro,J.D.,et al, 1980

Dementia From Aluminum Pots
NEJM 303:164, Levick,S.E., 1980

Pathological Verification of Ischemic Score in Differentiation of Dementias
Ann Neurol 7:486-488, Rosen,W.G.,et al, 1980

Alzheimer's Disease
Editorial, BMJ 281:1374-13751980., , 1980

Relationship between plaques, tangles, & dementia in Down syndrome
Neurol 30:639-644, Ropper,A.H.,et al, 1980

The Declining Incidence of Stroke
NEJM 300:449-452, Garraway,W.M.,et al, 1979

The Decreasing Incidence of Primary Intracerebral Hemorrhage:A Population Study
Ann Neurol 5:367-373, Furlan,A.J.,et al, 1979

Stroke Decline:Implications & Prospects
NEJM 300:490-491, Levy,R.I., 1979

Effects of Physostigmine & Lecithin on Memory in Alzheimer Disease
Ann Neurol 6:219-221, Peters,B.H.,et al, 1979

Enhancement Of Memory By Physostigmine
NEJM 301:946, Davis,K.L.,et al, 1979

Dementia in Parkinson Disease:A Neuropathologic Study
Neurol 29:1209-1214, Hakim,A.M.,et al, 1979

Lewy Bodies in the Presence of Alzheimer's Disease
Arch Neurol 36:170-171, Rosenblum,W.I.,et al, 1979

Alzheimer Neurofibrillary Tangles in Diseases Other Than Senile & Presenile Dementia
Ann Neurol 5:288-294, Wisniewski,K.,et al, 1979

Capgras Syndrome:A Reduplicative Phenomenon
Neurol 29:334-339, Alexander,M.P.,et al, 1979

Saikewicz Rule Does Not Apply to"No-Code"Order for Patient with Advanced Alzheimer Disease
Ann Neurol 6:142, Beresford,H.R., 1979

Cerebral Amyloid Angiopathy:Possible Relationship to Rheumatoid Vasculitis
Neurol 29:1336-1340, Mandybur,T.I., 1979

Studies in Aging of the Brain:IV. Familial Alzheimer Dis. :Relat. to Transmiss. Demetia, Aneuploidy, & Microtubular Defects
Neurol 29:1402, Book,R.H.,et al, 1979

Clinical Similarity of Alzheimer & Creutzfeldt-Jakob Disease
Ann Neurol 6:368-369, Watson,C.P., 1979

Clinical Syndromes of Myasthenia in Infancy & Childhood
Arch Neurol 35:97, Fenichel,G.M., 1978

Huntington Disease Associated with Alzheimer Disease
Ann Neurol 3:545, McIntosh,G.C.,et al, 1978

Possible Biochemical Basis of Memory Disorder in Alzheimer Disease
Ann Neurol 3:471, Smith,C.M.,et al, 1978

Precautions in Familial Transmissible Dementia
Arch Neurol 35:697-698, Cook,R.,et al, 1978

Familial Neuromuscular Disease with Type 1 Fiber Hypoplasia, Tubular Aggregates, Cardiomyopathy, & Myasthenic Features
Neurol 28:1135-1140, Dobkin,B.H.,et al, 1978

The Resolution of Discrepancies in the Reported Incidence of Primary Brain Tumors
Neurol 28:817-8-23, Schoenberg,B.S.,et al, 1978

Drug-Induced Myopathies In Man
Lancet 2:562-566, Lane,R.J.M.,et al, 1978

Presenile Dementia with Lewy Bodies & Neurofibrillary Tangles
Arch Neurol 35:818-822, Forno,L.S.,et al, 1978

Presenile Dementia Presenting as Aphasia
JNNP 40:303, Wechsler,A.F., 1977

Elevated Manganese Levels Associated with Dementia & Extrapyramidal Signs
Neurol 27:213, Banta,R.G.,et al, 1977

Alzheimer Neurofibrillary Change in Subacute Sclerosing Panencephalitis
Ann Neurol 1:103, Mandybur,T.I.,et al, 1977

Clofibrate-Induced Muscle Damage with Myoglobinuria & Cardiomyopathy
NEJM 296:942, Smals,A.G.H., 1977

Normal Pressure Hydrocephalus
In Wells C. E. Dementia 2nd Ed, F. A. Davis Co, Phila, P. 69-92, Katzman,R., 1977

Myasthenic Abduction Nystagmus in a Patient with Hyperthyroidism
Neurol 26:589, Finelli,P.F.&Hoyt,W., 1976

Myoclonus in Alzheimer Disease
Arch Neurol 33:278-280, Faden,A.I.,et al, 1976

The Prevalence & Malignancy of Alzheimer Disease
Arch Neurol 33:217-218, Katzman,R., 1976

Computerized Axial Tomography-Use in the Dx. of Dementia
JAMA 234:754, Menzer,L.,et al, 1975

Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease
NEJM 293:174, Genton,E.,et al, 1975

Epidemiology of Motor-Neuron Diseases
NEJM 288:1047, Bobwick,A.R.,et al, 1973

Alzheimers Disease with Abnormal CSF Flow
Neurol 23:1058, Sohn,R.S.,et al, 1973

Clinical Neuropathological Conference
(Ed) , Dis Ner Sys 34:124, 1973, Pick's Disease., Aronson,S.&Aronson,B., 1973

The Treatment of Cerebrovascular Disease with Clofibrate
VA Cooperative Study Group, Stroke 4:6841973., , 1973

Cancer-Incidence in Various Organs-Cancer 23:l4
1973 Jan/Feb., , 1973



Showing articles 850 to 900 of 910 << Previous Next >>